Cantor Fitzgerald Downgrades DICE Therapeutics (DICE) to Neutral following takeover
Tweet Send to a Friend
Cantor Fitzgerald analyst Prakhar Agrawal downgraded DICE Therapeutics (NASDAQ: DICE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
